Your browser doesn't support javascript.
loading
Binimetinib, pemetrexed and cisplatin, followed by maintenance of binimetinib and pemetrexed in patients with advanced non-small cell lung cancer (NSCLC) and KRAS mutations. The phase 1B SAKK 19/16 trial.
Froesch, Patrizia; Mark, Michael; Rothschild, Sacha I; Li, Qiyu; Godar, Gilles; Rusterholz, Corinne; Oppliger Leibundgut, Elisabeth; Schmid, Sabine; Colombo, Ilaria; Metaxas, Yannis; König, David; Sessa, Cristiana; Gautschi, Oliver; Früh, Martin.
Afiliação
  • Froesch P; Oncology Institute of Southern Switzerland, Via Ospedale, 6500 Bellinzona, Switzerland. Electronic address: patrizia.froesch@eoc.ch.
  • Mark M; Department of Medical Oncology/Hematology, Cantonal Hospital Graubünden, Loëstrasse 170, 7000 Chur, Switzerland. Electronic address: Michael.Mark@ksgr.ch.
  • Rothschild SI; Department of Medical Oncology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland. Electronic address: Sacha.Rothschild@usb.ch.
  • Li Q; SAKK Coordinating Center, Effingerstrasse 33, 3008 Bern, Switzerland. Electronic address: Qiyu.Li@sakk.ch.
  • Godar G; SAKK Coordinating Center, Effingerstrasse 33, 3008 Bern, Switzerland. Electronic address: Gilles.Godar@sakk.ch.
  • Rusterholz C; SAKK Coordinating Center, Effingerstrasse 33, 3008 Bern, Switzerland. Electronic address: Corinne.Rusterholz@sakk.ch.
  • Oppliger Leibundgut E; Department of Hematology, University Hospital Bern, and Department for BioMedical Research (DBMR), Bern University, 3010 Bern, Switzerland. Electronic address: elisabeth.oppligerleibundgut@insel.ch.
  • Schmid S; Department of Oncology/Hematology, Cantonal Hospital St.Gallen, Rorschacher Strasse 95, 9007 St.Gallen, Switzerland. Electronic address: sabine.schmid@uhn.ca.
  • Colombo I; Oncology Institute of Southern Switzerland, Via Ospedale, 6500 Bellinzona, Switzerland. Electronic address: Ilaria.Colombo@eoc.ch.
  • Metaxas Y; Department of Medical Oncology/Hematology, Cantonal Hospital Graubünden, Loëstrasse 170, 7000 Chur, Switzerland. Electronic address: ioannis.metaxas@ksgr.ch.
  • König D; Department of Medical Oncology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland. Electronic address: david.koenig@usb.ch.
  • Sessa C; Oncology Institute of Southern Switzerland, Via Ospedale, 6500 Bellinzona, Switzerland. Electronic address: Cristiana.Sessa@eoc.ch.
  • Gautschi O; Medical Oncology, Cantonal Hospital Lucerne, Spitalstrasse, 6004 Lucerne, Switzerland; University of Berne, Hochschulstrasse 6, 3012 Bern, Switzerland. Electronic address: oliver.gautschi@luks.ch.
  • Früh M; University of Berne, Hochschulstrasse 6, 3012 Bern, Switzerland; Department of Oncology/Hematology, Cantonal Hospital St.Gallen, Rorschacher Strasse 95, 9007 St.Gallen, Switzerland. Electronic address: Martin.Frueh@kssg.ch.
Lung Cancer ; 156: 91-99, 2021 06.
Article em En | MEDLINE | ID: mdl-33933896

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article